In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast...
Vous n'êtes pas connecté
A new study from the University of Michigan Health Rogel Cancer Center, USA, finds that giving a fatty acid inhibitor alongside chemotherapy could improve the treatment efficacy for patients with brain metastases from triple negative breast cancer. The findings appear in npj Breast Cancer. Previous work has shown that the brain microenvironment has very limited lipids [...]
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast...
WEDNESDAY, Oct. 23, 2024 -- Women fighting breast cancer can relieve some of their chemotherapy “brain fog” through aerobic exercise, a...
WEDNESDAY, Oct. 30, 2024 -- For patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy,...
A new study has revealed that a short course of chemotherapy before radiation therapy can significantly improve survival rates for cervical cancer...
Drugs aimed at HER2-positive breast cancer may also help certain patients with bile duct cancer, as indicated by findings from a patient trial that...
With over 27,000 women in the Philippines diagnosed with breast cancer in 2021 alone, the need for early detection and treatment has never been more...
Despite significant advancements in cancer treatment, drug resistance remains a persistent challenge. Cancer cells can often develop resistance to...
While significant progress has been made in awareness, detection, and treatment, breast cancer remains a leading cause of death, particularly in low-...
While significant progress has been made in awareness, detection, and treatment, breast cancer remains a leading cause of death, particularly in low-...